CG Oncology, Inc. revenue breakdown overview

CG Oncology, Inc. revenue for the last year amounted to 1.14 M USD, the most of which — 1.14 M USD — came from its highest performing source at the moment, Backbone Bladder-sparing Therapeutic, the year earlier bringing 204.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought CG Oncology, Inc. 1.14 M USD, and the year before that — 204.00 k USD.